• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后年龄与住院死亡率相关性的变化趋势:国家心血管数据注册研究。

Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry experience.

机构信息

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn 55905, USA.

出版信息

Circ Cardiovasc Interv. 2009 Feb;2(1):20-6. doi: 10.1161/CIRCINTERVENTIONS.108.826172. Epub 2009 Feb 10.

DOI:10.1161/CIRCINTERVENTIONS.108.826172
PMID:20031689
Abstract

BACKGROUND

Temporal trends and contemporary data characterizing the impact of patient age on in-hospital outcomes of percutaneous coronary interventions are lacking. We sought to determine the importance of age by assessing the in-hospital mortality of stratified age groups in the National Cardiovascular Data Registry.

METHODS AND RESULTS

In-hospital mortality after percutaneous coronary intervention on 1 410 069 patients was age stratified into 4 groups-group 1 (age <40, n=25 679), group 2 (40 to 59, n=496 204), group 3 (60 to 79, n=732 574), and group 4 (>or=80, n=155 612)-admitted from January 1, 2001, to December 31, 2006. Overall in-hospital mortality was 1.22%; in-hospital mortality was 0.60%, 0.59%, 1.26%, and 3.16% in groups 1 to 4, respectively, P<0.0001. Overall temporal improvement per calendar year in the adjusted in-hospital mortality after percutaneous coronary intervention was noted in most groups; however, this finding was significant only in the 2 older age groups, group 3 (odds ratio, 0.94; 95% CI, 0.92 to 0.96) and group 4 (odds ratio, 0.95; 95% CI, 0.92 to 0.97). The absolute mortality reduction was greatest in the most elderly group, those over the age of 80 years.

CONCLUSIONS

In-hospital mortality after percutaneous coronary intervention has fallen for all age groups over the past 6 years. However, the largest absolute reduction was seen among patients 80 years of age or older.

摘要

背景

目前缺乏关于患者年龄对经皮冠状动脉介入治疗住院结局影响的时间趋势和当代数据。我们旨在通过评估国立心血管数据注册中心各年龄组分层的住院死亡率来确定年龄的重要性。

方法和结果

1410069 例经皮冠状动脉介入治疗患者的住院死亡率按年龄分为 4 组:第 1 组(年龄<40 岁,n=25679)、第 2 组(40 至 59 岁,n=496204)、第 3 组(60 至 79 岁,n=732574)和第 4 组(年龄≥80 岁,n=155612),患者于 2001 年 1 月 1 日至 2006 年 12 月 31 日期间入院。总的住院死亡率为 1.22%;第 1 至 4 组的住院死亡率分别为 0.60%、0.59%、1.26%和 3.16%,P<0.0001。大部分组中均观察到经皮冠状动脉介入治疗后,随着时间推移每年调整后住院死亡率的改善,但仅在 2 个较年长的年龄组中具有统计学意义,第 3 组(比值比,0.94;95%可信区间,0.92 至 0.96)和第 4 组(比值比,0.95;95%可信区间,0.92 至 0.97)。最年长组(年龄>80 岁)的绝对死亡率降低幅度最大。

结论

过去 6 年来,所有年龄组经皮冠状动脉介入治疗后的住院死亡率均有所下降。然而,80 岁及以上患者的绝对死亡率降低幅度最大。

相似文献

1
Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry experience.经皮冠状动脉介入治疗后年龄与住院死亡率相关性的变化趋势:国家心血管数据注册研究。
Circ Cardiovasc Interv. 2009 Feb;2(1):20-6. doi: 10.1161/CIRCINTERVENTIONS.108.826172. Epub 2009 Feb 10.
2
Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York State.纽约州经皮冠状动脉介入治疗患者的血管疾病负担和住院结局。
Circ Cardiovasc Interv. 2009 Aug;2(4):317-22. doi: 10.1161/CIRCINTERVENTIONS.108.847459.108.847459. Epub 2009 Jul 22.
3
Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.75岁以上非选择性急性ST段抬高型心肌梗死患者的治疗方式及30天预后:来自BLITZ研究的数据
J Cardiovasc Med (Hagerstown). 2008 Oct;9(10):1045-51. doi: 10.2459/JCM.0b013e32830eb6eb.
4
Outcome and survival of patients aged 75 years and older compared to younger patients after ruptured abdominal aortic aneurysm repair: do the results justify the effort?与年轻患者相比,75岁及以上患者腹主动脉瘤破裂修复后的结局和生存率:这些结果是否证明付出的努力是值得的?
Ann Vasc Surg. 2009 Jul-Aug;23(4):469-77. doi: 10.1016/j.avsg.2008.10.009. Epub 2009 Jan 10.
5
Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: a multicenter analysis.既往经皮冠状动脉介入治疗对冠状动脉旁路移植术结局的影响:一项多中心分析。
J Thorac Cardiovasc Surg. 2009 Apr;137(4):840-5. doi: 10.1016/j.jtcvs.2008.09.005. Epub 2009 Jan 18.
6
Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.急性心肌梗死继发心源性休克患者急诊经皮冠状动脉介入治疗后的死亡率及死亡率预测模型的效用
Am J Cardiol. 2005 Jul 1;96(1):35-41. doi: 10.1016/j.amjcard.2005.02.040.
7
Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).三个年龄组(<60岁、60至80岁和>80岁)患者经皮冠状动脉介入治疗结果的比较(来自纽约州血管成形术登记处)。
Am J Cardiol. 2006 Nov 15;98(10):1334-9. doi: 10.1016/j.amjcard.2006.06.026. Epub 2006 Sep 28.
8
Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience.经皮冠状动脉介入治疗后住院及长期预后的25年趋势:单机构经验
Circulation. 2007 Jun 5;115(22):2835-41. doi: 10.1161/CIRCULATIONAHA.106.632679. Epub 2007 May 28.
9
Validation of the Mayo clinic risk score for in-hospital mortality after percutaneous coronary interventions using the national cardiovascular data registry.使用国家心血管数据注册中心验证梅奥诊所经皮冠状动脉介入治疗住院死亡率风险评分。
Circ Cardiovasc Interv. 2008 Aug;1(1):36-44. doi: 10.1161/CIRCINTERVENTIONS.107.755991.
10
Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry.年龄对经皮腔内冠状动脉成形术操作及1年预后的影响:美国国立心肺血液研究所动态注册研究报告
Am Heart J. 2003 Sep;146(3):513-9. doi: 10.1016/S0002-8703(03)00259-X.

引用本文的文献

1
Machine learning approaches for risk prediction after percutaneous coronary intervention: a systematic review and meta-analysis.经皮冠状动脉介入治疗后风险预测的机器学习方法:系统评价与荟萃分析
Eur Heart J Digit Health. 2024 Oct 14;6(1):23-44. doi: 10.1093/ehjdh/ztae074. eCollection 2025 Jan.
2
The Gut-Heart Axis: Molecular Perspectives and Implications for Myocardial Infarction.肠-心轴:分子视角与心肌梗死的意义。
Int J Mol Sci. 2024 Nov 20;25(22):12465. doi: 10.3390/ijms252212465.
3
Mid- to long-term efficacy and safety of stem cell therapy for acute myocardial infarction: a systematic review and meta-analysis.
干细胞治疗急性心肌梗死的中远期疗效及安全性的系统评价和荟萃分析。
Stem Cell Res Ther. 2024 Sep 11;15(1):290. doi: 10.1186/s13287-024-03891-1.
4
Stretching to Reduce Pain-Related Disability Among Echocardiographic and Interventional Laboratory Employees-A Pilot Study.伸展运动对减少超声心动图和介入实验室工作人员与疼痛相关的功能障碍的影响——一项初步研究
J Soc Cardiovasc Angiogr Interv. 2024 May 2;3(5):101353. doi: 10.1016/j.jscai.2024.101353. eCollection 2024 May.
5
Revascularization Modalities in Acute Coronary Syndrome: A Review of the Current State of Evidence.急性冠状动脉综合征的血运重建方式:证据现状综述
Cureus. 2023 Oct 17;15(10):e47207. doi: 10.7759/cureus.47207. eCollection 2023 Oct.
6
Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial.老年人慢性冠状动脉疾病的健康状况和临床结局:ISCHEMIA 试验。
J Am Coll Cardiol. 2023 May 2;81(17):1697-1709. doi: 10.1016/j.jacc.2023.02.048.
7
Incidence and predictors of cardiovascular outcomes after acute coronary syndrome in a population-based cohort study.基于人群队列研究的急性冠脉综合征后心血管结局的发生率及预测因素。
Sci Rep. 2023 Mar 1;13(1):3447. doi: 10.1038/s41598-023-30597-w.
8
Complex, high-risk percutaneous coronary intervention types, trends, and in-hospital outcomes among different age groups: An insight from a national registry.不同年龄段患者接受复杂高危经皮冠状动脉介入治疗类型、趋势及院内结局:来自全国注册登记研究的分析。
Catheter Cardiovasc Interv. 2022 Nov;100(5):711-720. doi: 10.1002/ccd.30366. Epub 2022 Sep 2.
9
Impact of age on reperfusion success and long-term prognosis in ST-segment elevation myocardial infarction - A cardiac magnetic resonance imaging study.年龄对ST段抬高型心肌梗死再灌注成功率及长期预后的影响——一项心脏磁共振成像研究
Int J Cardiol Heart Vasc. 2021 Mar 2;33:100731. doi: 10.1016/j.ijcha.2021.100731. eCollection 2021 Apr.
10
Should Percutaneous Coronary Intervention be the Standard Treatment Strategy for Significant Coronary Artery Disease in all Octogenarians?高龄 80 岁以上患者的严重冠状动脉疾病是否应采用经皮冠状动脉介入治疗作为标准治疗策略?
Curr Cardiol Rev. 2021;17(3):244-259. doi: 10.2174/1573403X16666200903153823.